Yıl: 2023 Cilt: 11 Sayı: 2 Sayfa Aralığı: 53 - 69 Metin Dili: İngilizce DOI: 10.32596/ejcm.galenos.2023.2023-01-012 İndeks Tarihi: 02-07-2023

The Efficiency of Magnesium Supplements for the Symptomatic Relief of Patients with Superficial Venous Reflux Disease

Öz:
Objectives: Patients with superficial venous reflux disease admit to the outpatient clinics with a wide range of symptoms. Although none of the marketed medications disappear the varicosities, they are helpful to relieve the symptoms of the patients to a certain degree. We investigated the influence of the addition of magnesium oxide (MO) to the standard symptomatic treatment of patients with superficial venous reflux disease. Materials and Methods: Thirty-two consecutive patients who were diagnosed with chronic superficial venous reflux disease were randomly divided into 2 groups. The first group (n=16) was treated with a Horse chestnut seed extract (HCSE)-calcium dobesilate combined therapy, whereas the second group was treated with HCSE-calcium dobesilate combined plus MO therapy. Results: The scores of symptoms including mean burning sensation, heaviness, cramps, edema, restlessness on the affected leg, and visual analog scale improved significantly in the second group with additional MO uptake at the end of the 2-week treatment period (p<0.05). Conclusion: The addition of MO into the symptomatic treatment regime of patients is associated with a more efficient relief in symptoms and associated with a significant decrease in edema when combined with other anti-varicose vein agents.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
0
0
0
  • 1. Kayssi A, Pope M, Vucemilo I, Werneck C. Endovenous radiofrequency ablation for the treatment of varicose veins. Can J Surg 2015;58:85-6.
  • 2. Beebe-Dimmer JL, Pfeifer JR, Engle JS, Schottenfeld D. The epidemiology of chronic venous insufficiency and varicose veins. Ann Epidemiol 2005;15:175-84.
  • 3. Erdinc I. Efficiency of endovenous laser and glue ablation methods in comparison with conventional surgery for the treatment of venous ulcers. Phlebology 2022;37:670-7.
  • 4. Neglen P. Treatment of varicosities of saphenous origin: comparison of ligation, selective excision, and sclerotherapy. Varicose veins and Teleangiectasias: Diagnosis and Treatment 1993;148-65.
  • 5. Ulukan MO, Karakaya A, Erkanli K, Beyaz MO, Oztas DM, Ugurlucan M. Efficiency of Prophylactic Ablation of the Tributary Venous Pathways Draining Around the Saphenofemoral Junction to Decrease the Rate of Future Varicose Vein and Symptoms Occurence. Ann Vasc Surg 2021;75:267-74.
  • 6. Beyaz MO, Bozkurt E, Onalan MA, et al. Evaluation of chronic inflammation in the aetiology of venous insufficiency by investigating cytomegalovirus DNA. Arch Med Sci 2022;18:129-32.
  • 7. Beyaz MO, Oztas DM, Ulukan MO, Arslan HM, Unal O, Ugurlucan M. Preliminary Results of a New Illuminated Radiofrequency Ablation Catheter for the Treatment of Great Saphenous Vein Reflux Disease. Surg Innov 2022;29:234-40.
  • 8. Pompilio G, Nicolaides A, Kakkos SK, Integlia D. Systematic literature review and network Meta-analysis of sulodexide and other drugs in chronic venous disease. Phlebology 2021;36:695-709.
  • 9. Qu X, Jin F, Hao Y, et al. Magnesium and the risk of cardiovascular events: a meta-analysis of prospective cohort studies. PLoS One 2013;8:e57720.
  • 10. Mayer ML, Westbrook GL, Guthrie PB. Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones. Nature 1984;309:261-3.
  • 11. Lurie F, Passman M, Meisner M, et al. The 2020 update of the CEAP classification system and reporting standards. J Vasc Surg Venous Lymphat Disord 2020;8:342-52.
  • 12. Cronenwett JL, Johnston KW. Rutherford’s Vascular Surgery e-book. 2-Volume Set (8th ed.), 2014. Faculty Bookshelf. 38.
  • 13. Widmer L, Biland L, Barras JP. Doxium 500 in chronic venous insufficiency: a double-blind placebo controlled multicentre study. Int Angiol 1990;9:105- 10.
  • 14. Mansilha A, Sousa J. Pathophysiological Mechanisms of Chronic Venous Disease and Implications for Venoactive Drug Therapy. Int J Mol Sci 2018;19:1669.
  • 15. Tejerina T, Ruiz E. Calcium dobesilate: pharmacology and future approaches. Gen Pharmacol 1998;31:357-60.
  • 16. McMillan DE, Utterback NG, Wujek JJ. Effect of anionic amphophiles on erythrocyte properties. Ann N Y Acad Sci 1983;416:633-41.
  • 17. Gloviczki P, Fowl RJ, Hollier LH, Dewanjee MK, Plate G, Kaye MP. Prevention of platelet deposition by ibuprofen and calcium dobesilate in expanded polytetrafluoroethylene vascular grafts. Am J Surg 1985;150:589- 92.
  • 18. Michal M, Gotti C. Effect of calcium dobesilate on platelet function. Thromb Res 1988;51:593-605.
  • 19. Rabe E, Jaeger KA, Bulitta M, Pannier F. Calcium dobesilate in patients suffering from chronic venous insufficiency: a double-blind, placebo- controlled, clinical trial. Phlebology 2011;26:162-8.
  • 20. Flota-Cervera F, Flota-Ruiz C, Trevino C, Berber A. Randomized, double blind, placebo-controlled clinical trial to evaluate the lymphagogue effect and clinical efficacy of calcium dobesilate in chronic venous disease. Angiology 2008;59:352-6.
  • 21. Rabe E, Ballarini S, Lehr L; Doxium EDX09/01 Study Group.Arandomized, double-blind, placebo-controlled, clinical study on the efficacy and safety of calcium dobesilate in the treatment of chronic venous insufficiency. Phlebology 2016;31:264-74.
  • 22. Rasheed K, Gupta D, Dubey A, Singh Y. A Review on β-Escin. Indian J Med Res Pharm Sci 2021;8:10-6.
  • 23. Pittler MH, Ernst E. Horse chestnut seed extract for chronic venous insufficiency. Cochrane Database Syst Rev 2012;11:CD003230.
  • 24. Smith PC. Daflon 500 mg and venous leg ulcer: new results from a meta- analysis. Angiology 2005;56(Suppl 1):S33-9.
  • 25. Kakkos SK, Nicolaides AN. Efficacy of micronized purified flavonoid fraction (Daflon(R)) on improving individual symptoms, signs and quality of life in patients with chronic venous disease: a systematic review and meta-analysis of randomized double-blind placebo-controlled trials. Int Angiol 2018;37:143-54.
  • 26. Suter A, Bommer S, Rechner J. Treatment of patients with venous insufficiency with fresh plant horse chestnut seed extract: a review of 5 clinical studies. Adv Ther 2006;23:179-90.
  • 27. Diehm C, Trampisch HJ, Lange S, Schmidt C. Comparison of leg compression stocking and oral horse-chestnut seed extract therapy in patients with chronic venous insufficiency. Lancet 1996;347:292-4.
  • 28. Pittler MH, Ernst E. Horse chestnut seed extract for chronic venous insufficiency. Cochrane Database Syst Rev 2006;CD003230.
  • 29. Kolte D, Vijayaraghavan K, Khera S, Sica DA, Frishman WH. Role of magnesium in cardiovascular diseases. Cardiol Rev 2014;22:182-92.
  • 30. Rosique-Esteban N, Guasch-Ferre M, Hernandez-Alonso P, Salas-Salvado J. Dietary Magnesium and Cardiovascular Disease: A Review with Emphasis in Epidemiological Studies. Nutrients 2018;10:168.
  • 31. Abbott RD, Ando F, Masaki KH, et al. Dietary magnesium intake and the future risk of coronary heart disease (the Honolulu Heart Program). Am J Cardiol 2003;92:665-9.
  • 32. Del Gobbo LC, Imamura F, Wu JH, et al. Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies. Am J Clin Nutr 2013;98:160-73.
  • 33. Marques B, Klein M, da Cunha MR, et al. Effects of Oral Magnesium Supplementation on Vascular Function: A Systematic Review and Meta- analysis of Randomized Controlled Trials. High Blood Press Cardiovasc Prev 2020;27:19-28.
  • 34. Vink R, Nechifor M, editors. Magnesium in the Central Nervous System [Internet]. Adelaide (AU): University of Adelaide Press; 2011. PMID: 29919999.
  • 35. Orlova S, Dikke G, Pickering G, et al. Risk factors and comorbidities associated with magnesium deficiency in pregnant women and women with hormone-related conditions: analysis of a large real-world dataset. BMC Pregnancy Childbirth 2021;21:76.
APA Önal B, ÖZTAŞ D, bıçakhan b, Hakgor A, Erdinç İ, YILDIZ Y, Ugurlucan M (2023). The Efficiency of Magnesium Supplements for the Symptomatic Relief of Patients with Superficial Venous Reflux Disease. , 53 - 69. 10.32596/ejcm.galenos.2023.2023-01-012
Chicago Önal Burak,ÖZTAŞ DİDEM,bıçakhan burcu,Hakgor Aykun,Erdinç İbrahim,YILDIZ YAHYA,Ugurlucan Murat The Efficiency of Magnesium Supplements for the Symptomatic Relief of Patients with Superficial Venous Reflux Disease. (2023): 53 - 69. 10.32596/ejcm.galenos.2023.2023-01-012
MLA Önal Burak,ÖZTAŞ DİDEM,bıçakhan burcu,Hakgor Aykun,Erdinç İbrahim,YILDIZ YAHYA,Ugurlucan Murat The Efficiency of Magnesium Supplements for the Symptomatic Relief of Patients with Superficial Venous Reflux Disease. , 2023, ss.53 - 69. 10.32596/ejcm.galenos.2023.2023-01-012
AMA Önal B,ÖZTAŞ D,bıçakhan b,Hakgor A,Erdinç İ,YILDIZ Y,Ugurlucan M The Efficiency of Magnesium Supplements for the Symptomatic Relief of Patients with Superficial Venous Reflux Disease. . 2023; 53 - 69. 10.32596/ejcm.galenos.2023.2023-01-012
Vancouver Önal B,ÖZTAŞ D,bıçakhan b,Hakgor A,Erdinç İ,YILDIZ Y,Ugurlucan M The Efficiency of Magnesium Supplements for the Symptomatic Relief of Patients with Superficial Venous Reflux Disease. . 2023; 53 - 69. 10.32596/ejcm.galenos.2023.2023-01-012
IEEE Önal B,ÖZTAŞ D,bıçakhan b,Hakgor A,Erdinç İ,YILDIZ Y,Ugurlucan M "The Efficiency of Magnesium Supplements for the Symptomatic Relief of Patients with Superficial Venous Reflux Disease." , ss.53 - 69, 2023. 10.32596/ejcm.galenos.2023.2023-01-012
ISNAD Önal, Burak vd. "The Efficiency of Magnesium Supplements for the Symptomatic Relief of Patients with Superficial Venous Reflux Disease". (2023), 53-69. https://doi.org/10.32596/ejcm.galenos.2023.2023-01-012
APA Önal B, ÖZTAŞ D, bıçakhan b, Hakgor A, Erdinç İ, YILDIZ Y, Ugurlucan M (2023). The Efficiency of Magnesium Supplements for the Symptomatic Relief of Patients with Superficial Venous Reflux Disease. E Journal of Cardiovascular Medicine, 11(2), 53 - 69. 10.32596/ejcm.galenos.2023.2023-01-012
Chicago Önal Burak,ÖZTAŞ DİDEM,bıçakhan burcu,Hakgor Aykun,Erdinç İbrahim,YILDIZ YAHYA,Ugurlucan Murat The Efficiency of Magnesium Supplements for the Symptomatic Relief of Patients with Superficial Venous Reflux Disease. E Journal of Cardiovascular Medicine 11, no.2 (2023): 53 - 69. 10.32596/ejcm.galenos.2023.2023-01-012
MLA Önal Burak,ÖZTAŞ DİDEM,bıçakhan burcu,Hakgor Aykun,Erdinç İbrahim,YILDIZ YAHYA,Ugurlucan Murat The Efficiency of Magnesium Supplements for the Symptomatic Relief of Patients with Superficial Venous Reflux Disease. E Journal of Cardiovascular Medicine, vol.11, no.2, 2023, ss.53 - 69. 10.32596/ejcm.galenos.2023.2023-01-012
AMA Önal B,ÖZTAŞ D,bıçakhan b,Hakgor A,Erdinç İ,YILDIZ Y,Ugurlucan M The Efficiency of Magnesium Supplements for the Symptomatic Relief of Patients with Superficial Venous Reflux Disease. E Journal of Cardiovascular Medicine. 2023; 11(2): 53 - 69. 10.32596/ejcm.galenos.2023.2023-01-012
Vancouver Önal B,ÖZTAŞ D,bıçakhan b,Hakgor A,Erdinç İ,YILDIZ Y,Ugurlucan M The Efficiency of Magnesium Supplements for the Symptomatic Relief of Patients with Superficial Venous Reflux Disease. E Journal of Cardiovascular Medicine. 2023; 11(2): 53 - 69. 10.32596/ejcm.galenos.2023.2023-01-012
IEEE Önal B,ÖZTAŞ D,bıçakhan b,Hakgor A,Erdinç İ,YILDIZ Y,Ugurlucan M "The Efficiency of Magnesium Supplements for the Symptomatic Relief of Patients with Superficial Venous Reflux Disease." E Journal of Cardiovascular Medicine, 11, ss.53 - 69, 2023. 10.32596/ejcm.galenos.2023.2023-01-012
ISNAD Önal, Burak vd. "The Efficiency of Magnesium Supplements for the Symptomatic Relief of Patients with Superficial Venous Reflux Disease". E Journal of Cardiovascular Medicine 11/2 (2023), 53-69. https://doi.org/10.32596/ejcm.galenos.2023.2023-01-012